CRISPR Therapeutics AG (CRSP) Common Equity (2015 - 2026)
CRISPR Therapeutics AG's Common Equity was $1.75 billion in Q2 2026, up 2.1% from $1.71 billion a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at CRISPR Therapeutics AG came in at $1.92 billion, down 0.5% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.93 billion in FY2024 (+2.6%), $1.88 billion in FY2023 (+0.4%), $1.88 billion in FY2022 (-21.8%) and $2.4 billion in FY2021 (+44.2%).
- Quarterly Common Equity has moved between $1.71 billion (Q2 2025) and $2.51 billion (Q3 2021) over five years.
- Compared with a year earlier, Common Equity was higher in three of the last eight quarters, with an average decline of 1.4%.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 87.1%); the worst was Q3 2022 (a decline of 22.2%).
- Per Business Quant data, CRSP's Common Equity in the three quarters before Q2 2026 was $1.81 billion (Q1 2026), $1.92 billion (Q4 2025) and $1.92 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 1.75 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.81 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Sep 30, 2025 | 1.92 Bn |
| Jun 30, 2025 | 1.71 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Dec 31, 2024 | 1.93 Bn |
| Sep 30, 2024 | 1.94 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 2.08 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Sep 30, 2023 | 1.73 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Sep 30, 2022 | 1.95 Bn |
| Jun 30, 2022 | 2.09 Bn |
| Mar 31, 2022 | 2.24 Bn |
| Dec 31, 2021 | 2.40 Bn |
| Sep 30, 2021 | 2.51 Bn |
API Access
CRISPR Therapeutics AG Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();